Madrigal Pharmaceuticals, Inc. ( MDGL) - Key Metrics
MDGL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $12.50 | -$1.99 | $0.80 | $0.65 |
| 2026Q1 | $10.72 | -$3.25 | -$5.77 | -$5.90 |
| 2025Q4 | $14.31 | -$2.61 | -$5.95 | -$5.93 |
| 2025Q3 | $12.78 | -$5.08 | $3.55 | $3.51 |
| 2025Q2 | $9.58 | -$1.90 | -$2.12 | -$2.12 |
MDGL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -67.46 |
| 2026Q1 | 0% | -40.27 |
| 2025Q4 | 0% | -56.65 |
| 2025Q3 | 0% | -22.57 |
| 2025Q2 | 0% | -39.82 |
MDGL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.12% | 0% |
| 2026Q1 | -1.13% | 0% |
| 2025Q4 | -1.02% | 0% |
| 2025Q3 | 0.77% | 0% |
| 2025Q2 | -0.70% | 0% |
MDGL
Price: $471.75
52 week price:
Earnings Per Share: -14.41 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 132314
Ebitda: -8.4 millionMarket Capitalization: 11.5 billion